Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M101,918Revenue $M149,200Net Margin (%)3.4Altman Z-Score3.7
Enterprise Value $M126,842EPS $4.5Operating Margin %6.2Piotroski F-Score7
P/E(ttm)20.9Beneish M-Score-2.5Pre-tax Margin (%)5.6Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %11.5Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %13.7Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow17.5y-y EBITDA Growth Rate %14.5ROA % (ttm)6.4Higher Current Ratio y-yY
Dividend Yield %1.6PEG1.5ROE % (ttm)14.0Less Shares Outstanding y-yY
Payout Ratio %30.0Shares Outstanding M1,107ROIC % (ttm)10.7Gross Margin Increase y-yN

Gurus Latest Trades with CVS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSRobert Olstein 2015-12-31 Add0.24%$91.56 - $105.29
($97.91)
$ 93.11-5%Add 42.22%64,000
CVSMario Gabelli 2015-12-31 Reduce-0.02%$91.56 - $105.29
($97.91)
$ 93.11-5%Reduce -3.03%1,178,788
CVSRichard Pzena 2015-12-31 Add$91.56 - $105.29
($97.91)
$ 93.11-5%Add 0.02%527,389
CVSJames Barrow 2015-12-31 Reduce$91.56 - $105.29
($97.91)
$ 93.11-5%Reduce -3.85%368,897
CVSKen Fisher 2015-12-31 Reduce$91.56 - $105.29
($97.95)
$ 93.11-5%Reduce -0.40%122,308
CVSVanguard Health Care Fund 2015-09-30 Reduce-0.17%$95.12 - $113.45
($105.29)
$ 93.11-12%Reduce -20.92%3,084,020
CVSRobert Olstein 2015-09-30 Reduce-0.13%$95.12 - $113.45
($105.29)
$ 93.11-12%Reduce -21.05%45,000
CVSJohn Rogers 2015-09-30 Sold Out -0.1%$95.12 - $113.45
($105.29)
$ 93.11-12%Sold Out0
CVSMario Gabelli 2015-09-30 Reduce-0.08%$95.12 - $113.45
($105.29)
$ 93.11-12%Reduce -10.62%1,215,593
CVSJoel Greenblatt 2015-09-30 Reduce-0.06%$95.12 - $113.45
($105.29)
$ 93.11-12%Reduce -77.20%20,797
CVSNWQ Managers 2015-09-30 Reduce-0.05%$95.12 - $113.45
($105.29)
$ 93.11-12%Reduce -4.44%783,473
CVSKen Fisher 2015-09-30 Reduce-0.01%$95.12 - $113.45
($105.29)
$ 93.11-12%Reduce -21.50%122,805
CVSJames Barrow 2015-09-30 Reduce$95.12 - $113.45
($105.29)
$ 93.11-12%Reduce -1.62%383,650
CVSNWQ Managers 2015-06-30 Reduce-0.46%$98.74 - $106.47
($102.19)
$ 93.11-9%Reduce -30.15%819,859
CVSJoel Greenblatt 2015-06-30 Reduce-0.14%$98.74 - $106.47
($102.19)
$ 93.11-9%Reduce -66.50%91,217
CVSMario Gabelli 2015-06-30 Reduce-0.04%$98.74 - $106.47
($102.19)
$ 93.11-9%Reduce -5.44%1,359,978
CVSTom Gayner 2015-06-30 Add0.01%$98.74 - $106.47
($102.19)
$ 93.11-9%Add 0.82%247,000
CVSJames Barrow 2015-06-30 Add0.01%$98.74 - $106.47
($102.19)
$ 93.11-9%Add 27.87%389,950
CVSKen Fisher 2015-06-30 Reduce$98.74 - $106.47
($102.19)
$ 93.11-9%Reduce -1.60%156,437
CVSRichard Pzena 2015-06-30 Add$98.74 - $106.47
($102.19)
$ 93.11-9%Add 0.02%527,265
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MERLO LARRY JPresident and CEO 2016-02-01Sell46,393$96.14-3.15view
MERLO LARRY JPresident and CEO 2016-01-11Sell46,393$95-1.99view
Brennan Troyen AEVP, Chief Medical Officer 2015-10-27Sell23,603$105-11.32view
Boratto Eva CSVP, Cont & Chief Acct Officer 2015-07-20Sell22,107$110.34-15.62view
Bisaccia LisaEVP, Chief HR Officer 2015-07-15Sell49,908$110-15.35view
BROWN C DAVID IIDirector 2015-06-01Sell10,000$102.57-9.22view
BROWN C DAVID IIDirector 2015-05-01Sell15,000$100.27-7.14view
Sussman AndrewEVP & Pres, CVS/minuteclinic 2015-04-10Sell17,638$102.38-9.05view
Brennan Troyen AEVP, Chief Medical Officer 2015-04-02Sell33,384$102.48-9.14view
Brennan Troyen AEVP, Chief Medical Officer 2015-03-23Sell33,274$104.94-11.27view

Quarterly/Annual Reports about CVS:

News about CVS:

Articles On GuruFocus.com
Mario Gabelli Comments on CVS Health Corp Feb 05 2016 
Steven Romick Sells Microsoft, Walgreens, CVS Jan 20 2016 
Louis Moore Bacon's Largest 3rd Quarter Trades Dec 23 2015 
First Pacific Advisors Slashes Stake in CVS Health Dec 17 2015 
Health Care Stocks Play Prominent Roles in Steven Romick's Transactions Dec 15 2015 
John Rogers Sells Position in CVS Dec 12 2015 
Taking a Look at Barron’s 10 Favorite Stocks for 2016 Dec 07 2015 
How the Walgreens-Rite Aid Deal Stacks Up Against Paulson's Merger Arbitrage Checklist Nov 05 2015 
Walgreens Buys Rite Aid to Avoid Loose Market Nov 04 2015 
How Rite Aid Deal Will Change Walgreens Oct 30 2015 

More From Other Websites
Cisco PT Raised; SolarCity Upgraded; Disney, CVS PTs Cut Feb 10 2016
US Stock Indices Fell: Why Did They Follow Oil Prices? Feb 10 2016
CVS Health Offering Meningitis Vaccines to Residents in Santa Clara County, CA Feb 10 2016
CVS Posts Healthy profit, Affirms 2016 Guidance (CVS) Feb 10 2016
CVS Health Company Accordant Earns NCQA Accreditation for Case Management Feb 10 2016
[$$] CVS Profit Grows on Higher Sales of Prescription Drugs Feb 10 2016
[$$] CVS Profit Grows, But Forecast Soft Feb 09 2016
Stocks End Little Changed After Choppy Trading Day Feb 09 2016
Edited Transcript of CVS earnings conference call or presentation 9-Feb-16 1:30pm GMT Feb 09 2016
U.S. stocks end flat after seesaw session amid oil slide Feb 09 2016
CVS Health fourth-quarter profit, revenue rise Feb 09 2016
CVS Meets, Beats Q4 Views Amid Challenges; Stock Rises Feb 09 2016
[$$] CVS: Right Prescription For a Higher Stock Price Feb 09 2016
Stocks Lower in Choppy Trading Feb 09 2016
CVS Health Posts In-Line Earnings, Tops Revenues in Q4 Feb 09 2016
CVS meets 4Q profit forecasts, reaffirms 2016 outlook Feb 09 2016
CVS meets 4Q profit forecasts, reaffirms 2016 outlook Feb 09 2016
CVS Health’s Drug Sales Are Booming Feb 09 2016
New Pharmacies And PBM Growth Boost CVS Health Profits Feb 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK